Shared Decision-Making and Cardiovascular Health

Modern cardiovascular guidelines are full of decisions that have no single right answer — whether to start a statin at borderline risk, how aggressively to chase a number, when to pursue more testing. These are choices that depend on what a particular patient values. This AHA statement is about how to make them well, together.

It assembles, from more than a hundred randomized trials, what is known about shared decision-making: the models that describe it, the tools — decision aids — that support it, and the evidence that when patients are genuinely informed and engaged, they understand their options better and choose more in line with their own priorities. It maps the practice across the full arc of care, from preventing a first event to planning for the end of life.

The statement’s distinctive emphasis is equity. It frames shared decision-making not as a courtesy but as a lever against disparity, and names the structural barriers — time, literacy, access, and racism — that keep it from happening in the rooms that need it most.

The honest limitation is measurement. “Shared decision-making” means different things in different studies, the outcomes are heterogeneous, and there is little trial evidence tying the practice to hard cardiovascular endpoints. It is well established that it improves the quality of decisions; it is harder to prove it changes the events that follow.

We rate the evidence strong as a synthesis. For a patient trying to navigate prevention efficiently, its real contribution is a reminder that the most evidence-based plan is also one the patient understood and agreed to.